ADAR1 Capital Management »

Cogent Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $472k 12k 38.70

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Zai Lab Adr (ZLAB)
Agios Pharmaceuticals (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Anteris Technologies Global (AVR)
Editas Medicine (EDIT)
Denali Therapeutics (DNLI)
Spyre Therapeutics Com New (SYRE)

View all positions for ADAR1 Capital Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
State Street Corporation
Fairmount Funds Management
Deerfield Management Company
TCG Crossover Management
Geode Capital Management
Wellington Management Company
Kynam Capital Management
Lord, Abbett & Co
Polar Capital Holdings

View all funds holding Cogent Biosciences